RxDoctor Payments DataLook up a doctor →

Tariq Hakky, MD

Urology · Atlanta, GANPI 1598990533

Payments from drug & device makers

$139,797in general payments, 2019–2025

Across 765 payments — averaging $182.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$132K
  • Boston Scientific$1K
  • Neotract Inc.$919
  • Zyla Life Sciences, Inc.$648
  • Endo Pharmaceuticals Inc.$595
  • Kerecis Limited$569
  • plus $4K from 38 others
$98,583in research payments, 2019–2025

Across 8 payments — averaging $12,323 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coloplast$99K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Coloplast358$132,003
Boston Scientific48$1,023
Neotract Inc.9$919
Zyla Life Sciences, Inc.105$648
Endo Pharmaceuticals Inc.30$595
Kerecis Limited9$569
Antares Pharma, Inc.38$547
Endo USA, Inc.19$284
Baxter Healthcare5$273
Medtronic(2 entities)13$263
Innovation Technologies Inc5$244
EDAP Technomed Inc8$208
Davol Inc.4$192
Viiv Healthcare Company8$191
Johnson & Johnson(2 entities)4$187
Laborie Medical Technologies Corp.5$150
Kowa Pharmaceuticals America, Inc.15$146
Astellas Pharma US Inc9$133
Tolmar, Inc.5$130
Acerus Pharmaceuticals Corporation8$127
Halozyme Inc6$105
AbbVie(2 entities)5$101
Pfizer6$101
Verity Pharmaceuticals Inc.6$100
Revance Therapeutics, Inc.1$81
Cook Medical LLC4$71
C. R. Bard, Inc. & Subsidiaries1$62
Blue Earth Diagnostics2$42
Galderma Laboratories, L.p.2$31
Travere Therapeutics, Inc.10$30
Teleflex LLC2$27
Musculoskeletal Transplant Foundation Inc.3$24
Trevena, Inc.1$22
Myriad Genetic Laboratories, Inc.1$21
Azurity Pharmaceuticals, Inc.1$20
Myovant Sciences Inc.1$20
Acell, Inc.1$19
Theratechnologies Inc.1$18
Procept Biorobotics Corporation1$18
Medline Industries LP1$14
Rigicon,inc.1$13
Olympus America Inc.1$12
Ferring Pharmaceuticals Inc.1$12
Assertio Therapeutics, Inc.1$3

How this compares

$139,797 in reported general payments places this provider in the 95th percentile of 369 urology providers in Georgia.

See all urology providers in Georgia →

Medicare billing

Part B allowed, 2024
$122,867
Medicare patients
141
Services billed
1,268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →